Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.25
+0.06 (0.83%)
Oct 21, 2025, 12:02 PM EDT - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $342.45 million as of October 21, 2025. Its market cap has decreased by -62.03% in one year.
Market Cap
342.45M
Enterprise Value
226.87M
1-Year Change
-62.03%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $342.45M, a decrease of -36.39%. That is a compound annual growth rate of -8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 339.61M | 4.55% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |